Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma

CONCLUSION: We conclude that a high sPD-L1 level is a biomarkerfor a poor outcome in HCC. The predictive value of sPD-L1 levels for a successful anti-PD1/PD-L1 therapy should be investigated in the future.PMID:33611059 | DOI:10.1016/j.intimp.2021.107467

Source: International Immunopharmacology - February 21, 2021 Category: Allergy & Immunology Authors: Tudor Mocan Maria Ilies Iuliana Nenu Rares Craciun Adelina Horhat Ruxandra Susa Iulia Minciuna Ioana Rusu Lavinia-Patricia Mocan Andrada Seicean Cristina Adela Iuga Nadim Al Hajjar Mihaela Sparchez Daniel-Corneliu Leucuta Zeno Sparchez Source Type: research